BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12503096)

  • 21. Impact of BRCA1 testing on women with cancer: a pilot study.
    Wood ME; Mullineaux L; Rahm AK; Fairclough D; Wenzel L
    Genet Test; 2000; 4(3):265-72. PubMed ID: 11142757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation.
    Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
    Genet Test; 2004; 8(1):13-21. PubMed ID: 15140370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic testing for breast and ovarian cancer risk: the psychosocial issues.
    Pasacreta JV; Jacobs L; Cataldo JK
    Am J Nurs; 2002 Dec; 102(12):40-7; quiz 48. PubMed ID: 12473929
    [No Abstract]   [Full Text] [Related]  

  • 24. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
    Beran TM; Stanton AL; Kwan L; Seldon J; Bower JE; Vodermaier A; Ganz PA
    Ann Behav Med; 2008 Oct; 36(2):107-16. PubMed ID: 18787910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review.
    Hamilton JG; Lobel M; Moyer A
    Health Psychol; 2009 Jul; 28(4):510-8. PubMed ID: 19594276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].
    Leblond D; Brédart A; Dolbeault S; De Pauw A; Stoppa Lyonnet D; Flahault C; Sultan S
    Bull Cancer; 2011 Feb; 98(2):184-98. PubMed ID: 21382771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychosocial aspects of predictive gene diagnosis in familial breast and ovarian carcinomas].
    von der Groeben C; Neef K; Rohde A; Bodden-Heidrich R; Schmutzler RK
    Dtsch Med Wochenschr; 1999 Mar; 124(12):361-2. PubMed ID: 10214370
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
    Arver B; Haegermark A; Platten U; Lindblom A; Brandberg Y
    Fam Cancer; 2004; 3(2):109-16. PubMed ID: 15340261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological adjustment among partners of women at high risk of developing breast/ovarian cancer.
    Mireskandari S; Sherman KA; Meiser B; Taylor AJ; Gleeson M; Andrews L; Tucker KM
    Genet Med; 2007 May; 9(5):311-20. PubMed ID: 17505209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
    Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    J Med Genet; 1999 Dec; 36(12):906-13. PubMed ID: 10593998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
    Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
    Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychological distress related to BRCA testing in ovarian cancer patients.
    Bjørnslett M; Dahl AA; Sørebø Ø; Dørum A
    Fam Cancer; 2015 Dec; 14(4):495-504. PubMed ID: 25980896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure.
    Claes E; Evers-Kiebooms G; Denayer L; Decruyenaere M; Boogaerts A; Philippe K; Legius E
    J Genet Couns; 2005 Oct; 14(5):349-63. PubMed ID: 16195942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer.
    den Heijer M; Vos J; Seynaeve C; Vanheusden K; Duivenvoorden HJ; Tilanus-Linthorst M; Menke-Pluymers MB; Tibben A
    Psychooncology; 2012 Feb; 21(2):153-60. PubMed ID: 22271535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer.
    Nordin K; Lidén A; Hansson M; Rosenquist R; Berglund G
    J Med Genet; 2002 Sep; 39(9):689-94. PubMed ID: 12205115
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
    Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A
    Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
    Struewing JP; Lerman C; Kase RG; Giambarresi TR; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):169-73. PubMed ID: 7742725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.